13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)
...... (read more)
Cytokinetics Inc (CYTK)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,721,888 | $41,198 | 4.17% | |
| 2. | Lansdowne Partners Alex Snow | 2,647,981 | $19,065 | 0.19% | |
| 3. | Birchview Capital Matthew Strobeck | 10,000 | $72 | 0.04% | |
| 4. | Palo Alto Investors William Leland Edwards | 123,686 | $891 | 0.03% | |
| 5. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 43,743 | $315 | -6% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.95 | 1,000 | Director | 1,850 | 2015-08-31 | Filing | |
| $6.48 | 200 | Director | 30,000 | 2015-08-20 | Filing | |
| $6.60 | 700 | Director | 29,800 | 2015-08-20 | Filing | |
| $6.60 | 4,980 | Director | 29,100 | 2015-08-20 | Filing | |
| $6.46 | 420 | Director | 24,120 | 2015-08-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.95 | 3,000 | Officer | 96,067 | 2018-06-07 | Filing | |
| $8.28 | 4,000 | Officer, Director | 176,022 | 2018-06-05 | Filing | |
| $8.40 | 1,500 | Officer, Director | 180,022 | 2018-05-04 | Filing | |
| $8.38 | 1,800 | Officer, Director | 181,522 | 2018-05-04 | Filing | |
| $8.35 | 400 | Officer, Director | 183,322 | 2018-05-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 93,309 | $672 | 0.58% | |
| 2. | 105,324 | $758 | 0.55% | |
| 3. | 1,761,882 | $12,686 | 0.16% | |
| 4. | 888,415 | $6,397 | 0.12% | |
| 5. | 84,690 | $610 | 0.08% |
News See All
Here’s What You Should Know About The Finance World Today
"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market. The Dow Jones Industrial Average DJIA, -0.57% dropped 124 points, or 0.6%, to 20,510, while the...... (read more)
Cytokinetics, Inc. (CYTK) Hedge Funds Are Snapping Up
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock...... (read more)
Cytokinetics Inc (CYTK): Mark Lampert’s Biotechnology Value Fund Loads Up On More Shares
Mark Lampert's Biotechnology Value Fund has filed a Form 13G on Cytokinetics, Inc. (NASDAQ:CYTK), one of its top-10 holdings at the end of 2015. The filing reveals an increase of nearly 1.00 million...... (read more)
Hedge Funds Are Buying Cytokinetics, Inc. (CYTK)
Before we spend many hours researching a company, we'd like to analyze what hedge funds and billionaire investors think of the stock first. We would like to do so because the elite investors' consensus...... (read more)
Cytokinetics, Inc. (CYTK) Conference Call Transcript – Expansion of Collaboration Agreement with Astellas
Good morning and welcome ladies and gentlemen to this Cytokinetics conference call. At this time I would like to inform you that this call is being recorded and that all participants are in a listen only...... (read more)
New Changes in SAC Capital’s 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other
In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves: reductions in the ownership of Annies Inc (NYSE:BNNY...... (read more)
Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)
Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK). According to a recent filing with the Securities and Exchange Commission, Lampert...... (read more)
Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)
At the moment, there are many indicators market participants can use to watch their holdings. Two of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies...... (read more)
Billionaire Hedge Funds
